EXEL - Exelixis reaches Cabometyx patent settlement with Cipla
2024-05-20 11:10:20 ET
More on Exelixis
- Exelixis: With Patent Litigation Decision Due Soon, There Are Options
- Exelixis files patent suit against India’s Cipla over Cabometyx generics
- Exelixis: Patent Woes And Challenging Market Dynamics Make For A Testy 2024
- Exelixis down 7% as Q1 financial results disappoint
- Exelixis, Inc. (EXEL) Q1 2024 Earnings Call Transcript